Back to search results

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Israel
RecruitingPHASE2, PHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Systemic Sclerosis Associated Interstitial Lung Disease · Scleroderma, Systemic

Locations
  • GSK Investigational Site, Phoenix, Arizona, United States
  • GSK Investigational Site, Scottsdale, Arizona, United States
  • GSK Investigational Site, Scottsdale, Arizona, United States
  • GSK Investigational Site, Tucson, Arizona, United States
  • GSK Investigational Site, Los Angeles, California, United States
  • GSK Investigational Site, Los Angeles, California, United States
  • GSK Investigational Site, Los Angeles, California, United States
  • GSK Investigational Site, Upland, California, United States
  • GSK Investigational Site, Aurora, Colorado, United States
  • GSK Investigational Site, Washington D.C., District of Columbia, United States
  • GSK Investigational Site, Jacksonville, Florida, United States
  • GSK Investigational Site, Miami, Florida, United States
  • GSK Investigational Site, Chicago, Illinois, United States
  • GSK Investigational Site, Baltimore, Maryland, United States
  • GSK Investigational Site, Ann Arbor, Michigan, United States
  • GSK Investigational Site, New Brunswick, New Jersey, United States
  • GSK Investigational Site, New York, New York, United States
  • GSK Investigational Site, New York, New York, United States
  • GSK Investigational Site, Potsdam, New York, United States
  • GSK Investigational Site, Cincinnati, Ohio, United States
  • GSK Investigational Site, Philadelphia, Pennsylvania, United States
  • GSK Investigational Site, Philadelphia, Pennsylvania, United States
  • GSK Investigational Site, Denison, Texas, United States
  • GSK Investigational Site, El Paso, Texas, United States
  • GSK Investigational Site, Houston, Texas, United States
  • GSK Investigational Site, Buenos Aires, Argentina
  • GSK Investigational Site, Ciudad Autonoma Buenos Aires, Argentina
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aire, Argentina
  • GSK Investigational Site, Liverpool, New South Wales, Australia
  • GSK Investigational Site, Adelaide, South Australia, Australia
  • GSK Investigational Site, Woodville, South Australia, Australia
  • GSK Investigational Site, Fitzroy, Victoria, Australia
  • GSK Investigational Site, Ghent, Belgium
  • GSK Investigational Site, Liège, Belgium
  • GSK Investigational Site, Belo Horizonte, Brazil
  • GSK Investigational Site, Curitiba, Brazil
  • GSK Investigational Site, Juiz de Fora, Brazil
  • GSK Investigational Site, Porto Alegre, Brazil
  • GSK Investigational Site, Porto Alegre, Brazil
  • GSK Investigational Site, Salvador, Brazil
  • GSK Investigational Site, São Paulo, Brazil
  • GSK Investigational Site, São Paulo, Brazil
  • GSK Investigational Site, Beijing, China
  • GSK Investigational Site, Beijing, China
  • GSK Investigational Site, Beijing, China
  • GSK Investigational Site, Beijing, China
  • GSK Investigational Site, Changchun, China
  • GSK Investigational Site, Chengdu, China
  • GSK Investigational Site, Chengdu, China
  • GSK Investigational Site, Luzhou, China
  • GSK Investigational Site, Mianyang, China
  • GSK Investigational Site, Nanjing, China
  • GSK Investigational Site, Nanjing, China
  • GSK Investigational Site, Nanning, China
  • GSK Investigational Site, Shanghai, China
  • GSK Investigational Site, Shanghai, China
  • GSK Investigational Site, Shenyang, China
  • GSK Investigational Site, Xi'an, China
  • GSK Investigational Site, Zhuzhou, China
  • GSK Investigational Site, Aarhus, Denmark
  • GSK Investigational Site, Odense C, Denmark
  • GSK Investigational Site, Turku, Finland
  • GSK Investigational Site, Bobigny, France
  • GSK Investigational Site, Brest, France
  • GSK Investigational Site, Paris, France
  • GSK Investigational Site, Paris, France
  • GSK Investigational Site, Paris, France
  • GSK Investigational Site, Toulouse, France
  • GSK Investigational Site, Cologne, Germany
  • GSK Investigational Site, Düsseldorf, Germany
  • GSK Investigational Site, Mainz, Germany
  • GSK Investigational Site, Minden, Germany
  • GSK Investigational Site, Tübingen, Germany
  • GSK Investigational Site, Athens, Greece
  • GSK Investigational Site, Athens, Greece
  • GSK Investigational Site, Heraklion Crete, Greece
  • GSK Investigational Site, Larissa, Greece
  • GSK Investigational Site, Thessaloniki, Greece
  • GSK Investigational Site, Haifa, Israel
  • GSK Investigational Site, Holon, Israel
  • GSK Investigational Site, Kfar Saba, Israel
  • GSK Investigational Site, Poria – Neve Oved, Israel
  • GSK Investigational Site, Ramat Gan, Israel
  • GSK Investigational Site, Tel Aviv, Israel
  • GSK Investigational Site, Ancona, Italy
  • GSK Investigational Site, Bari, Italy
  • GSK Investigational Site, Cagliari, Italy
  • GSK Investigational Site, Catania, Italy
  • GSK Investigational Site, Ferrara, Italy
  • GSK Investigational Site, Florence, Italy
  • GSK Investigational Site, Milan, Italy
  • GSK Investigational Site, Modena, Italy
  • GSK Investigational Site, Naples, Italy
  • GSK Investigational Site, Orbassano to, Italy
  • GSK Investigational Site, Padova, Italy
  • GSK Investigational Site, Pavia, Italy
  • GSK Investigational Site, Roma, Italy
  • GSK Investigational Site, Roma, Italy
  • GSK Investigational Site, Verona, Italy
  • GSK Investigational Site, Gunma, Japan
  • GSK Investigational Site, Hiroshima, Japan
  • GSK Investigational Site, Hokkaido, Japan
  • GSK Investigational Site, Hokkaido, Japan
  • GSK Investigational Site, Kanagawa, Japan
  • GSK Investigational Site, Miyagi, Japan
  • GSK Investigational Site, Shizuoka, Japan
  • GSK Investigational Site, Tokushima, Japan
  • GSK Investigational Site, Tokyo, Japan
  • GSK Investigational Site, Chihuahua City, Mexico
  • GSK Investigational Site, Guadalajara, Mexico
  • GSK Investigational Site, Mérida, Mexico
  • GSK Investigational Site, Torreón, Mexico
  • GSK Investigational Site, Seoul, South Korea
  • GSK Investigational Site, Seoul, South Korea
  • GSK Investigational Site, Seoul, South Korea
  • GSK Investigational Site, Seoul, South Korea
  • GSK Investigational Site, Suwon Kyunggi-do, South Korea
  • GSK Investigational Site, Barcelona, Spain
  • GSK Investigational Site, Barcelona, Spain
  • GSK Investigational Site, Bilbao, Spain
  • GSK Investigational Site, Granada, Spain
  • GSK Investigational Site, Madrid, Spain
  • GSK Investigational Site, Madrid, Spain
  • GSK Investigational Site, Seville, Spain
  • GSK Investigational Site, Valencia, Spain
  • GSK Investigational Site, VigoPontevedra, Spain
  • GSK Investigational Site, Birmingham, United Kingdom
  • GSK Investigational Site, Leeds, United Kingdom
  • GSK Investigational Site, London, United Kingdom
  • GSK Investigational Site, Portsmouth, United Kingdom
  • GSK Investigational Site, Wakefield, United Kingdom
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)